The pay gap between female and male employees not only exists but also increases as they advance in their careers. What can be done to reverse the trend?

Ameera Shah turned her father's nondescript clinic into one of the largest pathology chains in India.

Diagnostic tests have moved beyond identifying the ailment and are now guiding doctors on the line of treatment to follow.

Easier accreditation critical for laboratories.

The healthcare sector is poised for an eventful 2018, as medical and pharmaceutical firms await key policy announcements.

Apollo Hospitals Group Chairman Prathap C Reddy said: \"While we were hopeful that healthcare would be accorded a national priority sector status, the structural reform in medical education, in particular the increase in number of post graduate medical seats and DNB courses is praiseworthy as it was long-awaited.\"

The initial public offering (IPO) of Diagnostics company was oversubscribed 73.55 times in a price band of Rs 420-446.

Doctor Insta, the video medicine company is expanding its presence and has tied up with pharmacies and diagnostic labs in India allowing users to access necessary healthcare solutions without much hassle.

Till end of November, over 170 inspections were held in India as against over 70 inspection and certainly much less than 100 conducted five years ago by the US regulator in India.

The issue is being offered in the price band of Rs 540-550 per equity share and aims to garner Rs 626-638 crore from capital markets. Subscription will close on Thursday.

India's organised diagnostics industry is moving to the next level, as Dr Lal PathLabs, one of the oldest and largest in the industry, will tap the capital markets soon with an initial public offer (IPO).

Ameera Shah, Managing Director and CEO of Metropolis Healthcare Limited, in an interview with Business Today talks about the exit of promoter G.S.K. Velu.

An affiliate of Carlyle Asia Partners IV has bought a stake in Metropolis Healthcare Ltd, a multinational chain of pathology laboratories, Carlyle Group said in a statement.

Independent sources said the chain has a turnover of about Rs 550 crore and was valued between Rs 1,500 crore and Rs 1,800 crore a few months ago.

To build a nationwide chain, Shah tied up with local labs in many cities. Metropolis, which competes with Dr Lal PathLabs and SRL Diagnostics, now has 25 partners.

Even though it was set up shortly after India achieved independence, it is only in the past decade that Dr Lal PathLabs embarked on a major expansion drive and emerged as one of the country's largest chains of diagnostic centres.

Ameera Shah, MD & CEO, Metropolis Healthcare admires Mahatma Gandhi.